[{"NetIncomeLoss_1_Q2_USD":-23251000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":5042000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":24880387.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":25056123.0,"CommitmentsAndContingencies_0_Q2_USD":0.0,"AccruedLiabilitiesCurrent_0_Q2_USD":13026000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":318000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":61734000.0,"PaymentsToAcquireInvestments_2_Q2_USD":14020000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":-1000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":3000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":918000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":9734000.0,"AssetsCurrent_0_Q2_USD":152075000.0,"OperatingLeaseExpense_1_Q2_USD":200000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":5251457.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":25000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":890000.0,"CommonStockSharesIssued_0_Q2_shares":25394190.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":66294000.0,"Assets_0_Q2_USD":155766000.0,"ShareBasedCompensation_2_Q2_USD":5547000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":2107000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q2_shares":7104450.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"OperatingLeaseExpense_2_Q2_USD":300000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":44659000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_2_Q2_USD":25000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":357000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":4188000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_2_Q2_USD":61900000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":190000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":339000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-79000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-56000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":7000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":3000.0,"ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_2_Q2_USD":0.0,"CommonStockValue_0_Q2_USD":3000.0,"OperatingLeaseLiability_0_Q2_USD":3477000.0,"PaymentOfFinancingAndStockIssuanceCosts_2_Q2_USD":0.0,"DepreciationDepletionAndAmortization_2_Q2_USD":143000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_2_Q2_USD":35895000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q2_USD":18555000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":44684000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-44372000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-22909000.0,"OtherAssetsNoncurrent_0_Q2_USD":161000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":83042000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":2947000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":250349000.0,"Liabilities_0_Q2_USD":19558000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q2_USD":230000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":711000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":928000.0,"PaymentsForTenantImprovements_2_Q2_USD":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":71072000.0,"CommonStockSharesOutstanding_0_Q2_shares":25071337.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-44554000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-23248000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":2974000.0,"PreferredStockLiquidationPreferenceValue_0_Q2_USD":0.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-35345000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q2_USD":65398000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":865000.0,"LiabilitiesCurrent_0_Q2_USD":16580000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-114462000.0,"AccountsPayableCurrent_0_Q2_USD":3024000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_Q2_USD":-1000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q2_USD":81283000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.08,"IncreaseDecreaseInOtherOperatingAssets_2_Q2_USD":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":83042000.0,"AvailableForSaleSecuritiesGrossRealizedGainLossNet_2_Q2_USD":0.0,"AvailableForSaleSecuritiesGrossRealizedGainLossNet_1_Q2_USD":0.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":42000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":1423000.0,"NetIncomeLoss_2_Q2_USD":-44561000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":2739000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":7000.0,"LongTermInvestments_0_Q2_USD":0.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":151000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":36000.0,"CommonStockSharesAuthorized_0_Q2_shares":200000000.0,"OperatingIncomeLoss_2_Q2_USD":-45629000.0,"OperatingIncomeLoss_1_Q2_USD":-23597000.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_2_Q2_USD":0.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_1_Q2_USD":0.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":66294000.0,"InvestmentIncomeInterest_2_Q2_USD":1154000.0,"InvestmentIncomeInterest_1_Q2_USD":405000.0,"PreferredStockValue_0_Q2_USD":0.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":155766000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":2386000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":5547000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":2974000.0,"OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_1_Q2_USD":342000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":530000.0,"OperatingExpenses_2_Q2_USD":45629000.0,"OperatingExpenses_1_Q2_USD":23597000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":0.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.79,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.93,"ProfitLoss_2_Q2_USD":-44561000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":31000.0,"StockholdersEquity_0_Q2_USD":136208000.0,"ShortTermInvestments_0_Q2_USD":66294000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":918000.0,"Ticker":"MIRM","CIK":"1759425","name":"MIRUM PHARMACEUTICALS, INC.","OfficialName":"Mirum Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"824673616.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200806"}]